Your browser doesn't support javascript.
loading
Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients.
Avril, Stefanie; Dincer, Yasemin; Malinowsky, Katharina; Wolff, Claudia; Gündisch, Sibylle; Hapfelmeier, Alexander; Boxberg, Melanie; Bronger, Holger; Becker, Karl-Friedrich; Schmalfeldt, Barbara.
Afiliación
  • Avril S; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Dincer Y; Current address: Department of Pathology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center and Case Comprehensive Cancer Center, Cleveland, Ohio, United States.
  • Malinowsky K; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Wolff C; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Gündisch S; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Hapfelmeier A; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Boxberg M; Institute of Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany.
  • Bronger H; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Becker KF; Department of Obstetrics and Gynecology, Technische Universität München, Munich, Germany.
  • Schmalfeldt B; Institute of Pathology, Technische Universität München, Munich, Germany.
Oncotarget ; 8(58): 97851-97861, 2017 Nov 17.
Article en En | MEDLINE | ID: mdl-29228656

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania